Abstract
Biological tests of the hypertension work-up are used for two different purposes: to determine diagnosis and treatment and to detect rare diseases. For all patients, it is useful to conduct initial tests of plasma creatinine and potassium, and, very often, of plasma glucose, cholesterol and uric acid. A second group of tests is useful in a few patients for detection of surgically curable causes of hypertension.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alhenc-Gelas, F., Plouin, P. F., Ducrocq, M. B., Corvol, P. & Menard, J. (1978). Comparison of the antihypertensive and hormonal effects of a cardio-selective beta-blocker, acebutolol, and diuretics in essential hypertension. Am. J. Med., 64, 1005–1012.
Birkenhäger, W. H., de Leeuw, P. W., Wester, A., Kho, T. L., Vandongen, R. & Falke, H. E. (1977). Therapeutic effects of beta-adrenoceptor blocking agents in hypertension. In Advances in Internal Medicine and Pediatrics, ed. von Herausgegeben, P., Frick, G. A., von Harnack, G. A., Martini, A., Prader, R., Shoen, R. & Wolff, H. P. pp. 117–134. Springer-Verlag: Berlin, Heidelberg.
Bravo, E. L., Tarazi, R. C., & Dustan, H. P. (1975). Beta-adrenergic blockade in diuretic-treated patients with essential hypertension. New Eng. J. Med., 292, 66–70.
Bühler, F. R., Burkart, F., Lutold, B. E., Kung, M., Marbet, G. & Pfisterer, M. (1975). Antihypertensive beta-blocking action as related to renin and age. A pharmacological tool to identify pathogenetic mechanism in essential hypertension. Am. J. Cardiol., 36, 653–669.
Bühler, F. R., Laragh, J. H., Baer, L., Vaughan, E. D., Jr. & Brunner, H. R. (1972). Propranolol inhibition of renin secretion: a specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. New Eng. J. Med., 287, 1209–1214.
Collste, P. & Haglund, K. (1979). Time-course of blood pressure decrease during initiation of antihypertensive treatment with metoprolol. In 6th Scientific Meeting of the ISH, p. 126 Goteborg, June 11–13.
Distler, A., Keim, H. J., Cordes, U., Philipp, T. & Wolff, H. P. (1978). Sympathetic responsiveness and antihypertensive effect of beta-receptor blockade in essential hypertension. Am. J. Med., 64, 446–541.
Ducrocq, M. B., Degoulet, P., Charpentier, A., Corvol, P. & Menard, J. (1975). Le test à l’acébutolol dans l’hypertension artérielle modérée. Action sur les intervalles de temps systoliques. Nouv. Presse méd., 4, 3268–3272.
Hansson, L. (1973). Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity. Acta med. Scand., 550, 1–40.
Kreft, C., Menard, J. & Corvol, P. (1979). Value of renin measurement, saralasin test and acebutolol treatment in hypertension. Kidney Int., 15, 176–183.
Laragh, J. H. (1976). Modern system for treating high blood pressure based on renin profiling and vasoconstriction-volume analysis: a primary role for beta-blocking drugs such as propranolol. Am. J. Med., 61, 797–810.
Lehtonen, A. (1976). Atenolol in hypertension. Acta Ther., 2, 125–131.
Meekers, J., Missotten, A., Fagard, R., Demuynck, D., Harvengt, C., Pas, P., Billiet, L. & Amery, A. (1975). Predictive value of various parameters for the antihypertensive effect of the beta-blocker ICI 66, 082. Arch. int. Pharmacodvn. Ther., 213, 294–307.
Menard, J., Bertagna, X., N’Guyene, P. T., Degoulet, P. & Corvol, P. (1976). Rapid identification of patients with essential hypertension sensitive to acebutolol. Am. J. Med., 60, 886–890.
Menard, J. & Corvol, P. (1980): L’inhibition du système rénine-angiotensine: un progrès majeur dans le traitement de l’Hypertension Artérielle? Nouv. Presse méd., 9, 579–583.
Plouin, P. F., Alhenc-Gelas, F., Degoulet, P., Corvol, P. & Menard, J. (1980). Importance and limitation of PRA measurement for the choice of initial medication in ‘stepped-care’ treatment of hypertension. Cardiovasc. Rev. Rep., 1, 31–37.
Plouin, P. F., Comoy, E., Bohuon, C., Corvol, P. & Menard, J. (1979). Activité rénine et noradrénaline plasmatiques au cours du traitement antihypertenseur par l’acebutolol. Nouv. Presse méd., 8, 1905–1909.
Plouin, P. F., Menard, J., Corvol, P. & Milliez, P. (1978). Incidence des bêta-bloquants sur l’activité reénine plasmatique. Point Actuel. Nouv. Presse méd., 7, 2769–2774.
Stokes, G. S., Weber, M. A., Smith, J. V. & Gain, J. M. (1976). Double-blind cross-over study of propranolol and spironolactone in hypertension and plasma renin measurements in relation to therapeutic effects. In Systemic effects of antihypertensive agents, ed. Sambhi, M. P., pp. 265–284. New York: Stratton Intercontinental Medical Book Corporation.
Thibonnier, M., Lardoux, M. D. & Corvol, P. (1980). Comparative trial of labetalol and acebutolol, alone or associated with dihydralazine, in treatment of essential hypertension. Brit. J. clin. Pharmac., 9, 561–567.
Vaughan, E. D., Jr., Laragh, J. H., Gavras, I., Bühler, F. R., Gavras, H., Brunner, H. R. & Baer, L. (1973). Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone. Am. J. Cardiol., 32, 523–532.
Woods, J. W., Pittman, A. W. & Pulliam, C. C. (1976). Renin profiling in the treatment of hypertension. New Eng. J. Med., 294,1137–1143.
Author information
Authors and Affiliations
Editor information
Copyright information
© 1980 The contributors
About this chapter
Cite this chapter
Menard, J., Bautier, P., Plouin, P.F., Thibonnier, M., Corvol, P. (1980). β-Adrenoceptor Blocking Drugs and the Renin-Angiotensin System. In: Turner, P., Padgham, C., Hedges, A. (eds) Clinical Pharmacology & Therapeutics. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-05952-2_28
Download citation
DOI: https://doi.org/10.1007/978-1-349-05952-2_28
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-05954-6
Online ISBN: 978-1-349-05952-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)